Cytosorbents Corporation (CTSO)

Cytosorbents Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 4.67, with a low estimate of 1.00 and a high estimate of 10. The average target predicts an increase of 362.38% from the current stock price of 1.01.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.00	$4.67	$3.00	$10
Change	-0.99%	+362.38%	+197.03%	+890.10%

Analyst Ratings

The average analyst rating for Cytosorbents stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+890.10%	Apr 1, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+890.10%	Feb 25, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+890.10%	Jan 13, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+890.10%	Jan 3, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+890.10%	Nov 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

44.32M

Increased by 24.50%

from 35.59M

Revenue Next Year

53.97M

Increased by 21.77%

from 44.32M

EPS This Year

-0.21

from -0.38

EPS Next Year

-0.09

from -0.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	41.00M	43.17M	34.69M	36.35M	35.59M	44.32M	53.97M	65.89M
Revenue Growth	64.35%	5.27%	-19.64%	4.79%	-2.08%	24.50%	21.77%	22.09%
EPS	-0.20	-0.57	-0.75	-0.64	-0.38	-0.21	-0.09	-
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	47.8M	61.9M	80.7M
Avg	44.3M	54.0M	65.9M
Low	41.2M	47.5M	51.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	34.4%	39.7%	49.5%
Avg	24.5%	21.8%	22.1%
Low	15.7%	7.2%	-4.9%

EPS Forecast

EPS	2025	2026
High	-0.15	0.02
Avg	-0.21	-0.09
Low	-0.26	-0.14

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.